期刊文献+

2型糖尿病患者中合并Hp感染的临床观察

Clinical observation on patients with type 2 diabetes complicated with Hp infection
下载PDF
导出
摘要 目的:探究2型糖尿病患者中幽门螺杆菌(Hp)感染发病情况,并分析其高血压、高脂血症、高尿酸血症发病情况。方法:2013年1月1日-12月31日收治糖尿病患者986例,用14C呼气试验方法,观察感染组和非感染组合并高血压、高脂血症、高尿酸血症等情况,并对记录结果进行统计学的处理分析。结果:感染组的并发症情况明显重于非感染组,高血压、高脂血症、高尿酸血症等发病率均高于非感染组,差异具有统计学意义(P<0.05)。结论:2型糖尿病患者Hp感染发病率较高,这部分人群中高血压、高脂血症、高尿酸血症等情况越来越多,需要引起广大医学工作者的重视。 Objective:To explore the Helicobacter pylori(Hp) infection in patients with type 2 diabetes mellitus,and to analyze the incidence of hypertension,hyperlipidemia and hyperuricemia.Methods:986 patients with diabetic were selected from 1 January 2013 to 31 December 2013.We observed hypertension,hyperlipidemia,hyperuricemia and other conditions in the infection group and non infection group using the 14C breath test,and statistical analyzed the records of the results.Results:The complications of infection group was significantly higher than that of the non infection group,and the incidence of hypertension,hyperlipidemia and hyperuricemia were higher than the non infected group,with statistically significant difference(P<0.05).Conclusion:The infection rate of Hp in patients with type 2 diabetes mellitus was higher,and the incidence of hypertension,hyperlipidemia,hyperuricemia and other disease in this part of crowd was increasingly,so the medical workers need to pay more attention on it.
作者 唐晓彬 陈斯明 秦蕾 Tang Xiaobin;Chen Siming;Qin Lei(General Hospital of Jinlin Oil Field 138006)
机构地区 吉林油田总医院
出处 《中国社区医师》 2015年第13期73-74,共2页 Chinese Community Doctors
关键词 2型糖尿病 幽门螺杆菌(Hp) 14C呼气试验检测 临床观察 Type 2 diabetes mellitus Helicobacter pylori(Hp) 14C breath test Clinical observation
  • 相关文献

参考文献5

二级参考文献57

  • 1郑向东,周莉莉.泮托拉唑与奥美拉唑治疗消化性溃疡并出血临床分析[J].岭南急诊医学杂志,2005,10(1):28-29. 被引量:19
  • 2张沥,江梅,陶梅,张玲霞,曹广州,海春旭,秦绪军.热盐水致大鼠萎缩性胃炎血清和胃黏膜组织NO及NOS的动态变化[J].临床消化病杂志,2006,18(1):42-44. 被引量:8
  • 3姚方.埃索美拉唑在消化性溃疡病治疗中的地位[J].中华消化杂志,2006,26(5):355-357. 被引量:30
  • 4泮托拉唑临床验证协作组.泮托拉唑的药理作用于临床应用.中华消化杂志,2001,21(1):22-22.
  • 5Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv, 2007,4:165-174.
  • 6Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther, 2006,28:1712-1725.
  • 7Wagner J, Malchoff C, Abbott G. Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. Diabetes Technol Ther, 2005,7:612-619.
  • 8Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr, 2004,43:69-74.
  • 9Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems and current insulin users and non-users. Clin Ther, 2004,26:1498-1505.
  • 10Haak T, Edelman S, Walter C, et al. Comparison of usability and patient preference for the new disposable insulin device SoloStar versus FlexPen, Lilly disposable pen, and a prototype pen: an open-label study. Clin Ther, 2007,29:650-660.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部